You are here

  • Home
  • Archive
  • Volume 79, Issue 1
  • Effectiveness and cost-effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients

Article info

Article menu
Download PDFPDF
Paper
Effectiveness and cost-effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients

Authors

  • Mike Aristides aMedical Technology Assessment Group, Sydney, Australia, bHealth Economics and Outcomes Research, Research and Development, Eli-Lilly, Sydney, Australia PubMed articlesGoogle scholar articles
  • Michael Gliksman aMedical Technology Assessment Group, Sydney, Australia, bHealth Economics and Outcomes Research, Research and Development, Eli-Lilly, Sydney, Australia PubMed articlesGoogle scholar articles
  • Narayan Rajan aMedical Technology Assessment Group, Sydney, Australia, bHealth Economics and Outcomes Research, Research and Development, Eli-Lilly, Sydney, Australia PubMed articlesGoogle scholar articles
  • Peter Davey aMedical Technology Assessment Group, Sydney, Australia, bHealth Economics and Outcomes Research, Research and Development, Eli-Lilly, Sydney, Australia PubMed articlesGoogle scholar articles
  1. Mike Aristides, Director, M-TAG, PO Box 5639, Chatswood, NSW 2057, Australia.
View Full Text

Citation

Aristides M, Gliksman M, Rajan N, et al
Effectiveness and cost-effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients
Heart 1998;79:12-17.

Publication history

  • Accepted June 27, 1997
  • First published January 1, 1998.
Online issue publication 
January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

British Cardiac Society